1. Home
  2. Analysis
  3. Estring
  4. Zofran

Estring and Zofran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Estring and Zofran. Common interactions include interstitial lung disease among females.

The phase IV clinical study analyzes what interactions people who take Estring and Zofran have. It is created by eHealthMe based on reports of 30 people who take Estring and Zofran from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 29, 2023

30 people who take Estring and Zofran together, and have interactions are studied.

What is Estring?

Estring has active ingredients of estradiol. eHealthMe is studying from 4,546 Estring users for its effectiveness, alternative drugs and more.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 84,340 Zofran users for its effectiveness, alternative drugs and more.

Number of Estring and Zofran reports submitted per year:

Estring and Zofran drug interactions.

Common Estring and Zofran drug interactions by gender *:

female:

  1. Interstitial lung disease
  2. Pain
  3. Candidiasis
  4. Device related infection
  5. Sinus congestion
  6. Ear infection fungal
  7. Fatigue
  8. Otitis externa
  9. Otitis media
  10. Arthritis

male:

n/a

Common Estring and Zofran drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Haemorrhoids
  2. Hypercholesterolaemia
  3. Irritable bowel syndrome
  4. Learning disorder
  5. Lethargy
  6. Memory impairment
  7. Migraine
  8. Muscle spasms
  9. Neuropathy peripheral
  10. Osteoporosis

60+:

  1. Arthritis
  2. Azotaemia
  3. Fall
  4. Fatigue
  5. Glossodynia
  6. Headache
  7. Herpes virus infection
  8. Hyperhidrosis
  9. Hypervolaemia
  10. Hypoxia

Common conditions people have *:

  1. Immunodeficiency Common Variable: 14 people, 46.67%
  2. Pain: 4 people, 13.33%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 13.33%
  4. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 10.00%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.67%
  6. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 6.67%
  7. Insomnia (sleeplessness): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Estring and Zofran?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Estring and Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Estring side effects:

Browse all side effects of Estring:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zofran side effects:

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Estring interactions:

Browse all interactions between Estring and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zofran interactions:

Browse all interactions between Zofran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on estradiol and ondansetron hydrochloride (the active ingredients of Estring and Zofran, respectively), and Estring and Zofran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Estring and Zofran.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.